The FibroScan: A new tool for the noninvasive evaluation of fibrosis during chronic liver diseases;Le FibroScan: Un nouvel outil pour l'évaluation non invasive de la fibrose au cours des maladies chroniques du foie

Hepato-Gastro

Volumn 14, Issue 2, 2007, Pages 90-98

  Castera, Laurent ^a,b  

^a HÔPITAL SAINT ANDRÉ   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC LIVER DISEASE; CLINICAL EVALUATION; CLINICAL PRACTICE; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE SEVERITY; ELASTICITY; ELASTOGRAPHY; EQUIPMENT DESIGN; FIBEROSCOPE; FIBERSCOPE ENDOSCOPY; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER PARENCHYMA; NON INVASIVE PROCEDURE; PATHOGENESIS; PROGNOSIS; SCORING SYSTEM; SHORT SURVEY;

EID: 34047097255     PISSN: 12537020     EISSN: None     Source Type: Journal    
DOI: 10.1684/hpg.2007.0052     Document Type: Short Survey

References (31)

1. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mai F, et al. Transient elastography : a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003 ; 29 : 1705-13.
2. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005 ; 128 : 343-50.
3. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005 ; 41 : 48-54.
4. Marcellin P, De Ledinghen V, Dhumeaux D, Poupon R, Ziol M, Bedossa P, et al. Non invasive assessment of liver fibrosis in chronic hepatitis B using FibroScan (abstract). Hepatology 2005 ; 42 (Suppl. 1) : 715A.
5. de Ledinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2006 ; 41 : 175-9.
6. Corpechot C, El Naggar A, Poujol-Robert A, Ziol M, Wendum D, Chazouilleres O, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 2006 ; 43 : 1118-24.
7. Foucher J, Castéra L, Bernard PH, Adhoute X, Bertet J, Couzigou P, et al. Assessment of cirrhosis and its severity by FibroScan® and biochemical markers in alcoholic patients (abstract). J Hepatol 2006 ; 44 (Suppl.2) : S39.
8. de Ledinghen V, Beaugrand M, Kelleher T, Foucher J, Castera L, Ziol M, et al. Prediction of liver fibrosis in non alcoholic steatohepatitis (NASH) : risk factors and diagnostic potential of liver elasticity using FibroScan (abstract). J Hepatol 2006 ; 44 (Suppl.2) : S39.
9. Castera L, Pawlotsky JM. Noninvasive diagnosis of liver fibrosis in patients with chronic hepatitis C. Med Gen Med 2005 ; 7 : 39.
10. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection : a prospective study. Lancet 2001 ; 357 : 1069-75.
11. Wai CT, GreensonJK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003 ; 38 : 518-26.
12. Castera L, Le Bail B, Foucher J, Bertet J, Darriet M, Couzigou P, et al. Prospective analysis of discordance between FibroScan and FibroTest when used in combination as first-line assessment of liver fibrosis in chronic hepatitis C (Abstract). Hepatology 2005 ; 42 (Suppl. 1) : 440A.
13. Castera L, Foucher J, Bertet J, Couzigou P, de Ledinghen V. FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases. Hepatology 2006 ; 43 : 373-4.
14. Colletta C, Smirne C, Fabris C, Toniutto P, Rapetti R, Minisini R, et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005 ; 42 : 838-45.
15. Moreno-Otero R, Trapero-Marugan M, Mendoza J. Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase. Gut 2006 ; 55 : 1055-6.
16. Castera L, Foucher J, Bernard PH, Bertet J, Couzigou P, de Ledinghen V. Transient elastography (FibroScan) and FibroTest to assess liver fibrosis in inactive hepatitis B carriers : a prospective controlled study (abstract). Hepatology 2006 ; 44 (Suppl. 1) : 489A.
17. Melin P, Schoeny M, Dacon A, Gauchet A, Diebold MD. Dépistage non invasif de la fibrose hépatique : Intérêt du FibroScan® en consultation d'alcoologie. Alcoologie et Addictologie 2005 ; 27 : 191-6.
18. Castera L, Foucher J, Le Bail B, Bernard PH, Bertet J, Couzigou P, et al. Prospective and independent validation of the Lok index for prediction of cirrhosis in patients with chronic hepatitis C : comparison with FibroScan, Fibrotest and APRI (abstract). Gastroenterology 2006 ; 130 (Suppl.2) : A769.
19. Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan) : a prospective study. Gut 2006 ; 55(3) : 403-8.
20. Ganne-Carrié N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L, et al. Accuracy of liver stifness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006 ; 44 : 1511-7.
21. Poynard T, Halfon P, Castera L, Munteanu M, Imbert-Bismut F, Ratziu V, et al. La prévalence de chaque stade de fibrose est un facteur majeur de variabilité de I'estimation de la valeur diagnostique des marqueurs de fibrose par les courbes ROC (abstract). Gastroenterol Clin Biol 2006 ; 30 : 1039.
22. Kazemi F, Kettaneh A, N'Kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006 ; 45(2) : 230-5.
23. Carrion JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006 ; 12 : 1791-8.
24. Foucher J, Castera L, Bernard PH, Adhoute X, Laharie D, Bertet J, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006 ; 18 : 411-2.
25. Konate A, Reaud S, Quenemer E, Fouchard-Hubert I, Oberti F, Cales P. Liver stiffness measurement by transient elastography : predictive factors of accuracy and reproducibility (abstract). J Hepatol 2006 ; 44 (Suppl.2): S195.
26. Roulot D, Costes JL, Le Clesio H, Grando V, Beaugrand M. Liver stifness values in subjects without known risk factors for chronic liver diseases (abstract). Hepatology 2006 ; 44 (Suppl. 1) : 490A.
27. Corpechot C, El Naggar A, Poupon R. Gender and liver : is the liver stiffness weaker in weaker sex? Hepatology 2006 ; 44 : 513-4.
28. EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. J Hepatol 1999; 31 (Suppl 1) : 3-8.
29. Consensus NIH. Statement on management of hepatitis C : 2002. Hepatology 2002 ; 36 : S3-20.
30. Castera L, Denis J, Babany G, Roudot-Thoraval F. Evolving practices of non invasive markers of liver fibrosis in patients with chronic hepatitis C in France : time for new guidelines? J Hepatol 2007 ; 46 : 528-30.
31. www.has-sante.fr. Méthodes non invasives d'évaluation de la fibrose/cirrhose hépatique, décembre 2006.